Open AccessSPRR3, a novel miR‑338‑3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway
Author(s) -
Man Wu,
Qi Guo,
Xianjun Liu,
Linlin Wu
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11246
Subject(s) - clear cell renal cell carcinoma , pi3k/akt/mtor pathway , cancer research , cell growth , gene knockdown , biology , microrna , oncogene , protein kinase b , transfection , cell cycle , downregulation and upregulation , cell culture , cell , microbiology and biotechnology , signal transduction , medicine , pathology , renal cell carcinoma , gene , biochemistry , genetics